Non-Invasive Neuromodulation for Upper Extremity Function in Spinal Cord Injury: A Crossover Trial

Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversity of Alberta

About this trial

This study explores two promising therapies for restoring arm and hand function in people with chronic cervical spinal cord injury (SCI), a condition that affects independence and quality of life. It will compare transcutaneous spinal cord stimulation and paired corticospinal-motoneuronal stimulation, both combined with rehabilitation. Using a crossover design, participants will receive each therapy for two months, with a one-month washout period in between. Safety, effectiveness, and patient-reported outcomes like daily living ability and quality of life will be assessed, alongside changes in neural excitability. The results of this study may enable us to tailor treatments to individual needs, promoting personalized care and improved outcomes.

Eligibility criteria

Qualifiers

Cervical (C2-C8) level SCI

> 9 months post-injury

Traumatic SCI

AIS A-D

Disqualifiers

individuals with injury to the nervous system other than to the spinal cord

pregnant

Trial design

Treatments tested in this trial

  • Transcutaneous Cervical Spinal Cord Stimulation
  • Paired Corticospinal Motoneuronal Stimulation
  • Functional Task Practice

Treatment groups

10 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Alberta

Lead sponsor

Praxis Spinal Cord Institute

Collaborator